Clinical Trial: Study on the Evaluation Value of PCSK9 Combined with HMGB1/NETS for Criticality and Early Progression/Short-Term Prognosis in Patients with Acute Ischemic Stroke (China)

Posted On: 2026-08-27

China, Aug. 27 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Evaluation Value of PCSK9 Combined with HMGB1/NETS for Criticality and Early Progression/Short-Term Prognosis in Patients with Acute Ischemic Stroke'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130900

Registration Time: 2026/08/26

Type: Observational study

Primary Sponsor: West China Hospital of Sichuan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=272632

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Study on the Evaluation Value of PCSK9 Combined with HMGB1/NETS for Criticality and Early Progression/Short-Term Prognosis in Patients with Acute Ischemic Stroke (China)